The Contributions of Rare Inherited and Polygenic Risk to ASD in Multiplex Families

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2023 Jul 28

PMID 37506195

Authors

Matilde Cirnigliaro

Timothy S Chang

Stephanie A Arteaga

Laura Perez-Cano

Elizabeth K Ruzzo

Aaron Gordon

Lucy K Bicks

Jae-Yoon Jung

Jennifer K Lowe

Dennis P Wall

Daniel H Geschwind

Affiliations

Soon will be listed here.

Abstract

Autism spectrum disorder (ASD) has a complex genetic architecture involving contributions from both de novo and inherited variation. Few studies have been designed to address the role of rare inherited variation or its interaction with common polygenic risk in ASD. Here, we performed whole-genome sequencing of the largest cohort of multiplex families to date, consisting of 4,551 individuals in 1,004 families having two or more autistic children. Using this study design, we identify seven previously unrecognized ASD risk genes supported by a majority of rare inherited variants, finding support for a total of 74 genes in our cohort and a total of 152 genes after combined analysis with other studies. Autistic children from multiplex families demonstrate an increased burden of rare inherited protein-truncating variants in known ASD risk genes. We also find that ASD polygenic score (PGS) is overtransmitted from nonautistic parents to autistic children who also harbor rare inherited variants, consistent with combinatorial effects in the offspring, which may explain the reduced penetrance of these rare variants in parents. We also observe that in addition to social dysfunction, language delay is associated with ASD PGS overtransmission. These results are consistent with an additive complex genetic risk architecture of ASD involving rare and common variation and further suggest that language delay is a core biological feature of ASD.

Citing Articles

Deciphering the genetic basis of developmental language disorder in children without intellectual disability, autism or apraxia of speech.

Ormieres C, Lesieur-Sebellin M, Siquier-Pernet K, Delplancq G, Rio M, Parisot M Mol Autism. 2025; 16(1):10.

PMID: 39948625 PMC: 11823097. DOI: 10.1186/s13229-025-00642-8.

RPS23RG1 inhibits SORT1-mediated lysosomal degradation of MDGA2 to protect against autism.

Huo Y, Zhao D, Zhu X, Zheng N, Yang D, Meng J Theranostics. 2025; 15(4):1338-1352.

PMID: 39816685 PMC: 11729561. DOI: 10.7150/thno.100451.

Making sense of missense: challenges and opportunities in variant pathogenicity prediction.

Molotkov I, Mardis E, Artomov M Dis Model Mech. 2024; 17(12).

PMID: 39676521 PMC: 11683568. DOI: 10.1242/dmm.052218.

Associations between maternal gestational diabetes mellitus and offspring cerebral palsy: a two-sample Mendelian randomization study.

Peng H, Shu Y, Lu S, Fan Q, Zhang Y, Ming L Transl Pediatr. 2024; 13(11):1923-1932.

PMID: 39649654 PMC: 11621887. DOI: 10.21037/tp-24-260.

Whole-genome sequencing analysis of Japanese autism spectrum disorder trios.

Furukawa S, Kushima I, Kato H, Kimura H, Nawa Y, Aleksic B Psychiatry Clin Neurosci. 2024; 79(3):87-97.

PMID: 39610113 PMC: 11874045. DOI: 10.1111/pcn.13767.

References

Neale B, Kou Y, Liu L, Maayan A, Samocha K, Sabo A . Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012; 485(7397):242-5. PMC: 3613847. DOI: 10.1038/nature11011. View

Spielman R, McGinnis R, Ewens W . Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993; 52(3):506-16. PMC: 1682161. View

Ruzzo E, Perez-Cano L, Jung J, Wang L, Kashef-Haghighi D, Hartl C . Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks. Cell. 2019; 178(4):850-866.e26. PMC: 7102900. DOI: 10.1016/j.cell.2019.07.015. View

Werling D, Brand H, An J, Stone M, Zhu L, Glessner J . An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder. Nat Genet. 2018; 50(5):727-736. PMC: 5961723. DOI: 10.1038/s41588-018-0107-y. View

ORoak B, Stessman H, Boyle E, Witherspoon K, Martin B, Lee C . Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat Commun. 2014; 5:5595. PMC: 4249945. DOI: 10.1038/ncomms6595. View

Polioudakis D, de la Torre-Ubieta L, Langerman J, Elkins A, Shi X, Stein J . A Single-Cell Transcriptomic Atlas of Human Neocortical Development during Mid-gestation. Neuron. 2019; 103(5):785-801.e8. PMC: 6831089. DOI: 10.1016/j.neuron.2019.06.011. View

An J, Lin K, Zhu L, Werling D, Dong S, Brand H . Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder. Science. 2018; 362(6420). PMC: 6432922. DOI: 10.1126/science.aat6576. View

Serdarevic F, Tiemeier H, Jansen P, Alemany S, Xerxa Y, Neumann A . Polygenic Risk Scores for Developmental Disorders, Neuromotor Functioning During Infancy, and Autistic Traits in Childhood. Biol Psychiatry. 2019; 87(2):132-138. DOI: 10.1016/j.biopsych.2019.06.006. View

Dong S, Walker M, Carriero N, DiCola M, Willsey A, Ye A . De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Rep. 2014; 9(1):16-23. PMC: 4194132. DOI: 10.1016/j.celrep.2014.08.068. View

10.

Fu J, Satterstrom F, Peng M, Brand H, Collins R, Dong S . Rare coding variation provides insight into the genetic architecture and phenotypic context of autism. Nat Genet. 2022; 54(9):1320-1331. PMC: 9653013. DOI: 10.1038/s41588-022-01104-0. View

11.

ORoak B, Vives L, Girirajan S, Karakoc E, Krumm N, Coe B . Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012; 485(7397):246-50. PMC: 3350576. DOI: 10.1038/nature10989. View

12.

Allen A, Cossette P, Delanty N, Eichler E, Goldstein D, Han Y . De novo mutations in epileptic encephalopathies. Nature. 2013; 501(7466):217-21. PMC: 3773011. DOI: 10.1038/nature12439. View

13.

Singh T, Walters J, Johnstone M, Curtis D, Suvisaari J, Torniainen M . The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat Genet. 2017; 49(8):1167-1173. PMC: 5533219. DOI: 10.1038/ng.3903. View

14.

Gaugler T, Klei L, Sanders S, Bodea C, Goldberg A, Lee A . Most genetic risk for autism resides with common variation. Nat Genet. 2014; 46(8):881-5. PMC: 4137411. DOI: 10.1038/ng.3039. View

15.

Kenny L, Hattersley C, Molins B, Buckley C, Povey C, Pellicano E . Which terms should be used to describe autism? Perspectives from the UK autism community. Autism. 2015; 20(4):442-62. DOI: 10.1177/1362361315588200. View

16.

Bucan M, Abrahams B, Wang K, Glessner J, Herman E, Sonnenblick L . Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 2009; 5(6):e1000536. PMC: 2695001. DOI: 10.1371/journal.pgen.1000536. View

17.

Wang J, Raskin L, Samuels D, Shyr Y, Guo Y . Genome measures used for quality control are dependent on gene function and ancestry. Bioinformatics. 2014; 31(3):318-23. PMC: 4308666. DOI: 10.1093/bioinformatics/btu668. View

18.

Kang H, Kawasawa Y, Cheng F, Zhu Y, Xu X, Li M . Spatio-temporal transcriptome of the human brain. Nature. 2011; 478(7370):483-9. PMC: 3566780. DOI: 10.1038/nature10523. View

19.

Conrad D, Keebler J, DePristo M, Lindsay S, Zhang Y, Casals F . Variation in genome-wide mutation rates within and between human families. Nat Genet. 2011; 43(7):712-4. PMC: 3322360. DOI: 10.1038/ng.862. View

20.

Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A, Klei L . Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am J Hum Genet. 2014; 94(5):677-94. PMC: 4067558. DOI: 10.1016/j.ajhg.2014.03.018. View